Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has one oncology program in clinical ...

 
May 02, 2013
REDX PHARMA AND PHARMASCIENCE ENTER INTO LICENSE AGREEMENT FOR cFMS CANCER PROGRAM
December 11, 2012
Pharmascience Inc. regains global rights for IAP inhibitor oncology program AEG40826 (HGS1029) from Human Genome Sciences